Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,572,917
-$133,923 QoQ
Shares Held
148,377
+12.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#740
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IHT Wealth Management, LLC holds $107,151,979 across 12 Drug Manufacturers - General names. PFE ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,510 | $42,591,762 | |
| 2 | ABBV |
AbbVie Inc.
|
78,550 | $19,766,322 | |
| 3 | JNJ |
Johnson & Johnson
|
62,778 | $15,943,728 | |
| 4 | MRK |
Merck & Co., Inc.
|
57,265 | $7,358,552 | |
| 5 | AMGN |
Amgen Inc
|
13,902 | $5,034,192 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
72,038 | $4,150,829 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
31,870 | $4,026,455 | |
| 8 | PFE |
Pfizer Inc
This page
|
148,377 | $3,572,917 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,572,917 | 148,377 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,706,840 | 132,010 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,914,296 | 117,040 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,530,624 | 177,811 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,259,161 | 175,708 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,158,826 | 164,121 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,254,881 | 160,380 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,201,646 | 179,739 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,873,467 | 138,437 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,597,565 | 129,642 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,858,501 | 99,288 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,798,519 | 84,369 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,808,550 | 76,569 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $3,136,418 | 76,873 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,778,078 | 73,733 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $3,084,204 | 70,480 | Shares | Sole | 2022-11-22 | |
| 2022-06-30 | $3,027,098 | 57,736 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,982,728 | 57,615 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,165,139 | 53,601 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,374,152 | 55,200 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,497,732 | 89,319 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,597,312 | 99,291 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $3,541,195 | 96,202 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $3,286,371 | 89,547 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $1,854,059 | 56,699 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,276,571 | 69,748 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||